Oak Grove Capital LLC Pfizer Inc Transaction History

Oak Grove Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	SELL	$39.39 - $51.28 $9,926 - $12,922	-252 Reduced 4.46%	5,400 $220,000
Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $300,600 - $392,400	-7,200 Reduced 56.02%	5,652 $289,000
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $711,909 - $844,101	-15,300 Reduced 54.35%	12,852 $674,000
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $371,880 - $551,250	-9,000 Reduced 24.22%	28,152 $1.66 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $673,216 - $864,803	17,152 Added 85.76%	37,152 $1.6 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $718,199 - $813,600	20,000 New	20,000 $783,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Oak Grove Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Grove Capital LLC with notifications on news.